Dec 04, 2021 05:39 PM (GMT+8) · EqualOcean
Financial Associated Press, Dec. 4 - Zhang Yuntao, vice president and chief scientist of Sinopharm China biology, said that from the current speculation, the effectiveness of various vaccines for mutant strains will decline, but from the preliminary analysis, the decline of inactivated vaccine may be relatively small, "because it is a full antigen vaccine, and it is a better vaccine to deal with mutation", From the perspective of dealing with Delta and other mutant strains, compared with vaccines of other technical routes, inactivated vaccines have given good answers, and the test of Omicron is ongoing.

This text is a result of machine translation.